8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Glaucoma in 1 studies
8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Osborne, NN | 1 |
Wood, JP | 1 |
Melena, J | 1 |
Chao, HM | 1 |
Nash, MS | 1 |
Bron, AJ | 1 |
Chidlow, G | 1 |
1 review available for 8-hydroxy-2-(di-n-propylamino)tetralin and Glaucoma
Article | Year |
---|---|
5-Hydroxytryptamine1A agonists: potential use in glaucoma. Evidence from animal studies.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Glaucoma; Intraocular Pressure; Neuroprotective Age | 2000 |